Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial
Published in Trials, 2022
This publication is available via DOI.
Recommended citation: Van Rie, A., De Vos, E., Costa, E., Verboven, L., Ndebele, F., Heupink, T.H., Abrams, S., Maraba, N., Makkan, H., Beattie, T., Sibeko, Z.R., Bohlela, S., Segwaba, P., Ogunbayo, E.A., Mhlambi, N., Wells, F., Rigouts, L., Maartens, G., Conradie, F., Black, J., Potgieter, S., Fanampe, B., Van der Spoel Van Dyk, A., Charalambous, S., Churchyard, G., & Warren, R. (2022) "Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial." Trials. 23(1).